Results 231 to 240 of about 64,876 (258)

Role of anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma. [PDF]

Front Pharmacol
Zhou Y, Huang S, Yang B, Tan J, Zhang Z, Liu W.   +5 more
europepmc   +1 more source

Recurrent bladder urothelial carcinoma complicated with primary bladder large cell neuroendocrine carcinoma: a case report and literature review. [PDF]

Front Oncol
Cui J, Zhao Q, Yu C, Ma P, Li S.
europepmc   +1 more source

Blockade of the STAT3/BCL-xL Axis Leads to the Cytotoxic and Cisplatin-Sensitizing Effects of Fucoxanthin, a Marine-Derived Carotenoid, on Human Bladder Urothelial Carcinoma Cells. [PDF]

Mar Drugs
Dai WC, Chen TH, Peng TC, He YC, Hsu CY, Chang CC.   +5 more
europepmc   +1 more source

Using machine learning to develop preoperative model for lymph node metastasis in patients with bladder urothelial carcinoma. [PDF]

BMC Cancer
Ji J, Zhang T, Zhu L, Yao Y, Mei J, Sun L, Zhang G.   +6 more
europepmc   +1 more source

TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma. [PDF]

Pathologica
Brunelli M, Gobbo S, Malpeli G, Sirgiovanni G, Caserta C, Munari E, Francesconi S, Caliò A, Martignoni G, Cimadamore A, Veccia A, Antonelli A, Tucci M, Pierconti F, Hattab IM, Eccher A, Ascani S, Milella M, Buffoni L, Cheng L, Bracarda S.   +20 more
europepmc   +1 more source

Quantitative differentiation of non-invasive bladder urothelial carcinoma and inverted papilloma based on CT urography. [PDF]

BMC Urol
Jin P, Yang L, Liu Y, Huang J, Wang X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Atezolizumab in Urothelial Bladder Carcinoma

Future Oncology, 2017
Metastatic bladder cancer is an aggressive malignancy with a poor prognosis when presenting with advanced stage. Cisplatin-based therapy has been the mainstay of first-line treatment but therapy in second-line setting has been an unmet medical need for decades. Moreover, many patients are unable to receive cisplatin-based therapy.
Zineb, Hamilou, Pernelle, Lavaud, Yohann, Loriot   +2 more
openaire   +2 more sources

Urothelial Histopathology Surrounding Bladder Carcinomas

European Urology, 1987
We studied the histological condition of the urothelium surrounding bladder carcinomas in 65 patients who underwent partial resection of the bladder. These examinations showed that urothelial abnormalities were always present, i.e. a direct transition from tumour to normal urothelium was never observed. The histological alterations were divided into 10
R, Brünger, G E, Schubert
openaire   +2 more sources

Bladder Neck Urothelial Carcinoma

International Journal of Surgical Pathology, 2015
To evaluate the clinicopathology of carcinomas originating in the urinary bladder neck, 316 cystectomies for urinary bladder carcinoma performed between January 1, 2008, and December 31, 2013, were analyzed. Clinicopathological parameters were compared between bladder neck carcinomas (BNCs) and non-BNCs. Among the 316 cystectomies were 19 BNCs and 297
Guang-Qian, Xiao, Hani, Rashid
openaire   +2 more sources

Non‐urothelial carcinomas of the bladder

Histopathology, 2018
Non‐urothelial carcinomas involving the bladder are uncommon and often diagnostically challenging. These carcinomas may show squamous, adenocarcinomatous or neuroendocrine features, with immunohistochemical stains aiding the diagnosis in only a subset of cases.
Sanghui Park, Victor E Reuter, Donna E Hansel   +2 more
openaire   +2 more sources